Stephan Chabardes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stephan Chabardes has a total of 506 co-authors. Here are the top co-authors by number of shared publications:
- Olivier David
Institut de Neuroscience des Systèmes, Aix Marseille University, Marseille, France
10 shared publications - Ludvic Zrinzo
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK
8 shared publications Brigitte Piallat
7 shared publicationsMircea Polosan
36.Université Grenoble Alpes, Grenoble, France
7 shared publications- Paul Krack
University Hospital Bern, University of Bern
7 shared publications Alim Louis Benabid
Univ. Grenoble Alpes, CEA
6 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in Movement Disorders
Fifteen‐Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism
Background: Bilateral pallidal deep brain stimulation ( GPi ‐ DBS ) is effective for dystonia. Long‐term evolution of therapeutic benefit and emergence of parkinsonism have not been systematically characterized. Objectives: To assess 15‐year dystonia outcomes and characterize parkinsonism after bilateral GPi ‐ DBS . Methods: Dystonia severity and disability were evaluated at baseline,1, 3, and 15 years postoperatively with the Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS). Parkinsonism was assessed at last visit using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III and freezing of gait (FoG) questionnaire. Results: Of 17 patients reassessed at 15 years, 41% maintained clinical benefit. Parkinsonism was observed in 94%, predominantly axial, with self‐reported FoG in 67%. Higher baseline BFMDRS‐Motor scores predicted last follow‐up axial parkinsonism ( R = 0.800, P < 0.001). Conclusions: Over 15 years, interindividual therapeutic benefit diverged while axial parkinsonism emerged in nearly all patients. These findings highlight the need for systematic long‐term monitoring extending beyond dystonia control after GPi‐DBS. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 3 September 2026
- Published by Wiley in Movement Disorders
Open AccessFifteen‐Year Outcomes of Bilateral Pallidal Stimulation in Isolated Generalized Dystonia: Characterization of Therapeutic Response and Emergence of Parkinsonism
Background: Bilateral pallidal deep brain stimulation ( GPi ‐ DBS ) is effective for dystonia. Long‐term evolution of therapeutic benefit and emergence of parkinsonism have not been systematically characterized. Objectives: To assess 15‐year dystonia outcomes and characterize parkinsonism after bilateral GPi ‐ DBS . Methods: Dystonia severity and disability were evaluated at baseline,1, 3, and 15 years postoperatively with the Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS). Parkinsonism was assessed at last visit using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III and freezing of gait (FoG) questionnaire. Results: Of 17 patients reassessed at 15 years, 41% maintained clinical benefit. Parkinsonism was observed in 94%, predominantly axial, with self‐reported FoG in 67%. Higher baseline BFMDRS‐Motor scores predicted last follow‐up axial parkinsonism ( R = 0.800, P < 0.001). Conclusions: Over 15 years, interindividual therapeutic benefit diverged while axial parkinsonism emerged in nearly all patients. These findings highlight the need for systematic long‐term monitoring extending beyond dystonia control after GPi‐DBS. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
- 3 September 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Assessing the effect of subthalamic stimulation on metaperception in obsessive-compulsive disorder
Most human studies on perceptual decision-making are correlational, and few addressed the causal role of the neural markers they identify. Here, we took the opportunity offered by deep brain stimulation to study the causal role of subthalamo-cortical networks on perceptual decision-making and perceptual monitoring. We asked participants with obsessive-compulsive disorder (OCD) treated with subthalamic stimulation to detect visual stimuli and provide confidence reports while we recorded scalp electroencephalography. Following a preregistered plan, we compared behavioural and neural results between patients off-stimulation and matched healthy controls and among patients on and off-stimulation to identify the effect of subthalamic stimulation on perceptual choices and metacognitive judgments. Our results indicate that patients off-stimulation detected visual stimuli similarly to matched healthy controls but provided poorer confidence judgments, indicative of a potential metacognitive alteration. Moreover, chronic subthalamic stimulation significantly reduced clinical symptoms, but acute stimulation changes did not impact visual detection, confidence, nor corresponding event-related potentials at the scalp level. We conclude that acute changes in subthalamic stimulation are insufficient to modify the potential metacognitive alterations observed in OCD.
- 3 September 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessAssessing the effect of subthalamic stimulation on metaperception in obsessive-compulsive disorder
Most human studies on perceptual decision-making are correlational, and few addressed the causal role of the neural markers they identify. Here, we took the opportunity offered by deep brain stimulation to study the causal role of subthalamo-cortical networks on perceptual decision-making and perceptual monitoring. We asked participants with obsessive-compulsive disorder (OCD) treated with subthalamic stimulation to detect visual stimuli and provide confidence reports while we recorded scalp electroencephalography. Following a preregistered plan, we compared behavioural and neural results between patients off-stimulation and matched healthy controls and among patients on and off-stimulation to identify the effect of subthalamic stimulation on perceptual choices and metacognitive judgments. Our results indicate that patients off-stimulation detected visual stimuli similarly to matched healthy controls but provided poorer confidence judgments, indicative of a potential metacognitive alteration. Moreover, chronic subthalamic stimulation significantly reduced clinical symptoms, but acute stimulation changes did not impact visual detection, confidence, nor corresponding event-related potentials at the scalp level. We conclude that acute changes in subthalamic stimulation are insufficient to modify the potential metacognitive alterations observed in OCD.
- 22 June 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-33
Deep Brain Stimulation for Sleep-Wake Regulation: A Narrative Review
Sleep-wake disorders are common in numerous neurological and psychiatric conditions, yet current treatments often yield incomplete results. Given the subcortical nature of sleep regulation, intracranial stimulation, and particularly deep brain stimulation (DBS), emerges as a promising therapeutic strategy. This narrative review synthesizes preclinical and clinical evidence regarding the effects of DBS and DBS-like invasive stimulation across multiple brain regions implicated in sleep-wake (SW) control. Additionally, stimulation targeting non-SW related targets has also shown incidental effects on sleep and wakefulness. Evidence reveals target- and frequency-dependent effects on sleep architecture and arousal, with notable translational success in Parkinson’s Disease and Obsessive-Compulsive Disorder. The discussion addresses three central questions: (1) Which brain areas modulate sleep and wakefulness when stimulated? (2) How do stimulation parameters influence these outcomes? (3) What are the challenges and limitations in moving toward sleep–wake–primary indications? Despite encouraging results, variability in reported measures and outcomes underscores the need for objective, standardized sleep measures (polysomnography) and advanced targeting. Overall, this review may assist clinicians in optimizing DBS parameters in patients experiencing sleep–wake disturbances and underscores the broader potential of invasive neuromodulation both as a therapeutic strategy and as a tool to better characterize sleep and wakefulness dynamics.
- 22 June 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- p. 1-33
Deep Brain Stimulation for Sleep-Wake Regulation: A Narrative Review
Sleep-wake disorders are common in numerous neurological and psychiatric conditions, yet current treatments often yield incomplete results. Given the subcortical nature of sleep regulation, intracranial stimulation, and particularly deep brain stimulation (DBS), emerges as a promising therapeutic strategy. This narrative review synthesizes preclinical and clinical evidence regarding the effects of DBS and DBS-like invasive stimulation across multiple brain regions implicated in sleep-wake (SW) control. Additionally, stimulation targeting non-SW related targets has also shown incidental effects on sleep and wakefulness. Evidence reveals target- and frequency-dependent effects on sleep architecture and arousal, with notable translational success in Parkinson’s Disease and Obsessive-Compulsive Disorder. The discussion addresses three central questions: (1) Which brain areas modulate sleep and wakefulness when stimulated? (2) How do stimulation parameters influence these outcomes? (3) What are the challenges and limitations in moving toward sleep–wake–primary indications? Despite encouraging results, variability in reported measures and outcomes underscores the need for objective, standardized sleep measures (polysomnography) and advanced targeting. Overall, this review may assist clinicians in optimizing DBS parameters in patients experiencing sleep–wake disturbances and underscores the broader potential of invasive neuromodulation both as a therapeutic strategy and as a tool to better characterize sleep and wakefulness dynamics.
- Open Access
- 7 April 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 97 (6) , 532-541
Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis
Background Psychiatric disorders are increasingly contributing to global disability. Despite advances in conservative management, the prevalence of treatment-resistant cases remains high. Meanwhile, neurosurgery for psychiatric disorders (NPD) remains underused, largely due to strict regulations and historical concerns, particularly those related to neuropsychological side effects (NPSE). Objective To address this issue, we conducted a systematic review with meta-analysis to compare NPSE associated with radiofrequency ablative NPD to those observed in neuro-oncological, neurovascular and epilepsy surgeries. Methods PubMed, Embase and LILACS databases were searched in April 2024 for articles published in English/Spanish from 1990 to 2022, following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Results A total of 48 articles with 2678 participants were included. The frequency of transient and permanent NPSE in the NPD group ranged from 0.94% to 11.50% and 0.94% to 2.03%, respectively, comparable to the other surgical groups (epilepsy: 0.31–11.70%; vascular: 0.52–22.90%; oncology: 0.94–17.60% for transient NPSE; epilepsy: 0.31–12%; vascular: 0.40–1.96% and oncology: 0.84–1.48% for permanent NPSE). Regarding permanent NPSE, arguably the most critical consideration, the NPD group showed better outcomes in memory, language and social cognition than the epilepsy group, but worse outcomes in executive and perceptual-motor functions. Compared with the vascular group, the NPD group had better executive function but worse complex attention. Finally, the NPD group had fewer permanent deficits than the oncology group in executive function, complex attention and perceptual-motor domains, although language performance was lower. Conclusions Contemporary NPD apparently carries a similar risk of NPSE as other conventional neurosurgical procedures, challenging misconceptions and this unjustified barrier to its broader use.
- 7 April 2026
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 97 (6) , 532-541
Open AccessComparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis
Background Psychiatric disorders are increasingly contributing to global disability. Despite advances in conservative management, the prevalence of treatment-resistant cases remains high. Meanwhile, neurosurgery for psychiatric disorders (NPD) remains underused, largely due to strict regulations and historical concerns, particularly those related to neuropsychological side effects (NPSE). Objective To address this issue, we conducted a systematic review with meta-analysis to compare NPSE associated with radiofrequency ablative NPD to those observed in neuro-oncological, neurovascular and epilepsy surgeries. Methods PubMed, Embase and LILACS databases were searched in April 2024 for articles published in English/Spanish from 1990 to 2022, following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Results A total of 48 articles with 2678 participants were included. The frequency of transient and permanent NPSE in the NPD group ranged from 0.94% to 11.50% and 0.94% to 2.03%, respectively, comparable to the other surgical groups (epilepsy: 0.31–11.70%; vascular: 0.52–22.90%; oncology: 0.94–17.60% for transient NPSE; epilepsy: 0.31–12%; vascular: 0.40–1.96% and oncology: 0.84–1.48% for permanent NPSE). Regarding permanent NPSE, arguably the most critical consideration, the NPD group showed better outcomes in memory, language and social cognition than the epilepsy group, but worse outcomes in executive and perceptual-motor functions. Compared with the vascular group, the NPD group had better executive function but worse complex attention. Finally, the NPD group had fewer permanent deficits than the oncology group in executive function, complex attention and perceptual-motor domains, although language performance was lower. Conclusions Contemporary NPD apparently carries a similar risk of NPSE as other conventional neurosurgical procedures, challenging misconceptions and this unjustified barrier to its broader use.
- Open Access
Deep brain stimulation of the thalamus for intractable epilepsy (FRANCE study): A randomized clinical trial
Objective: This study was undertaken to evaluate the efficacy and safety of deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) compared with best medical treatment (BMT) in patients with drug‐resistant epilepsy (DRE). Methods: This randomized, open‐label, phase 3 controlled trial was conducted across 14 specialized epilepsy and DBS centers. Eligible participants were adults with focal or multifocal DRE who had previously failed vagus nerve stimulation (VNS). Sixty‐one patients were randomized 1:1 either to receive continuous bilateral ANT‐DBS ( n = 30) or to continue BMT, including VNS ( n = 31), for 12 months. Afterward, patients in the BMT group were offered delayed ANT‐DBS and followed for an additional year. The primary outcome was the change in monthly severe seizure frequency (defined on the modified Chalfont Scale) at 12 months. Safety outcomes were also recorded. Results: Among 67 screened patients, 61 were enrolled. At 12 months, median seizure reduction was greater in the DBS group (−44%, interquartile range [IQR] = −67 to 0) versus the BMT group (−6%, IQR = –56 to 20; p = .09); 44.5% of patients in the DBS group achieved a ≥50% reduction in seizure frequency compared to 27% in the BMT group. Within‐group analyses showed significant seizure reductions in the DBS group at both 12 months (−44%, p < .001) and 24 months (−46%, p < .001), as well as in the delayed DBS group at 12 months (−36%, IQR = –73 to −4; p < .001). No significant differences in quality of life were observed between groups, and no major DBS‐related adverse events were reported. Significance: Our study suggests a potential benefit rather than demonstrating superiority of ANT‐DBS over medical therapy. However, within‐group improvements and favorable safety profile support the use of ANT‐DBS as a palliative treatment option in patients with DRE who have failed VNS.
Open AccessDeep brain stimulation of the thalamus for intractable epilepsy (FRANCE study): A randomized clinical trial
Objective: This study was undertaken to evaluate the efficacy and safety of deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) compared with best medical treatment (BMT) in patients with drug‐resistant epilepsy (DRE). Methods: This randomized, open‐label, phase 3 controlled trial was conducted across 14 specialized epilepsy and DBS centers. Eligible participants were adults with focal or multifocal DRE who had previously failed vagus nerve stimulation (VNS). Sixty‐one patients were randomized 1:1 either to receive continuous bilateral ANT‐DBS ( n = 30) or to continue BMT, including VNS ( n = 31), for 12 months. Afterward, patients in the BMT group were offered delayed ANT‐DBS and followed for an additional year. The primary outcome was the change in monthly severe seizure frequency (defined on the modified Chalfont Scale) at 12 months. Safety outcomes were also recorded. Results: Among 67 screened patients, 61 were enrolled. At 12 months, median seizure reduction was greater in the DBS group (−44%, interquartile range [IQR] = −67 to 0) versus the BMT group (−6%, IQR = –56 to 20; p = .09); 44.5% of patients in the DBS group achieved a ≥50% reduction in seizure frequency compared to 27% in the BMT group. Within‐group analyses showed significant seizure reductions in the DBS group at both 12 months (−44%, p < .001) and 24 months (−46%, p < .001), as well as in the delayed DBS group at 12 months (−36%, IQR = –73 to −4; p < .001). No significant differences in quality of life were observed between groups, and no major DBS‐related adverse events were reported. Significance: Our study suggests a potential benefit rather than demonstrating superiority of ANT‐DBS over medical therapy. However, within‐group improvements and favorable safety profile support the use of ANT‐DBS as a palliative treatment option in patients with DRE who have failed VNS.
- Open Access
A Multi-Symptom Circuit Architecture of Obsessive–Compulsive Disorder
Obsessive–compulsive disorder (OCD) manifests with diverse symptom constellations that likely arise from dysfunction in partially distinct neural circuits. Deep brain stimulation (DBS), paired with high-resolution connectomics, offers a unique window into these pathways in humans. Here, we analyzed clinical outcomes and stimulation sites from 77 treatment-refractory patients with OCD and 39 with Tourette’s syndrome (TS) exhibiting comorbid obsessive–compulsive behaviors (244 electrodes across 15 cohorts and eight targets). Engagement of the previously defined OCD response tract predicted global obsessive-compulsive symptom improvement across heterogeneous targets and diagnoses, spanning both OCD and TS. Beyond broad symptoms, obsessions, compulsions, anxiety, and depression mapped onto distinct yet overlapping subcircuits fragmenting the anterior limb of the internal capsule along a dorsoventral axis. This fine-scale architecture of OCD circuit dysfunction was reproducible across cross-validation schemes and patient subsets. Exploratory analyses identified additional subcircuits for cognitive control and flexibility. Global functional recovery was better explained by combined engagement of multiple symptom-specific rather than a single tract. Collectively, these findings illustrate how invasive neuromodulation can delineate a multi-symptom circuit taxonomy of compulsivity that may guide personalized neuromodulation.
Open AccessA Multi-Symptom Circuit Architecture of Obsessive–Compulsive Disorder
Obsessive–compulsive disorder (OCD) manifests with diverse symptom constellations that likely arise from dysfunction in partially distinct neural circuits. Deep brain stimulation (DBS), paired with high-resolution connectomics, offers a unique window into these pathways in humans. Here, we analyzed clinical outcomes and stimulation sites from 77 treatment-refractory patients with OCD and 39 with Tourette’s syndrome (TS) exhibiting comorbid obsessive–compulsive behaviors (244 electrodes across 15 cohorts and eight targets). Engagement of the previously defined OCD response tract predicted global obsessive-compulsive symptom improvement across heterogeneous targets and diagnoses, spanning both OCD and TS. Beyond broad symptoms, obsessions, compulsions, anxiety, and depression mapped onto distinct yet overlapping subcircuits fragmenting the anterior limb of the internal capsule along a dorsoventral axis. This fine-scale architecture of OCD circuit dysfunction was reproducible across cross-validation schemes and patient subsets. Exploratory analyses identified additional subcircuits for cognitive control and flexibility. Global functional recovery was better explained by combined engagement of multiple symptom-specific rather than a single tract. Collectively, these findings illustrate how invasive neuromodulation can delineate a multi-symptom circuit taxonomy of compulsivity that may guide personalized neuromodulation.
- Open Access
Intracranial Stimulation in Epilepsy as a Novel Approach for Mapping Psychiatric Circuits
Objective: To assess the feasibility of using stereo-electroencephalography (SEEG) depth electrodes, implanted for invasive recording of the epileptogenic zone in drug-resistant epilepsy, to identify and validate novel Deep Brain Stimulation (DBS) targets for psychiatric disorders. Methods: SEEG data from 86 patients with drug-resistant epilepsy implanted at the UK National Hospital for Neurology and Neurosurgery were analysed (6,372 electrode contacts). Normative structural and functional connectomes were combined with meta-analytic functional maps to estimate the probability of each contact engaging networks associated with psychiatric symptoms. A linear model, developed using published data from 80 patients with obsessive-compulsive disorder (OCD) treated with DBS, was used to validate the approach. Results: Networks involved in reward processing emerged as the most promising DBS targets, with a predicted required sample size of 7 patients (range 4–33). Bipolar disorder was the next most feasible (22 patients; range 10–44), followed by depression (32; range 16–49) and anxiety (38; range 17–59). For other disorders, estimated sample sizes exceeded 40, indicating limited feasibility for single-centre studies. Conclusions: This study provides preliminary support for using SEEG to map brain circuits underlying psychiatric symptoms. The method leverages routinely implanted electrodes in epilepsy to explore candidate DBS targets, supporting a network-guided strategy for personalised neuromodulation in neuropsychiatry.
Open AccessIntracranial Stimulation in Epilepsy as a Novel Approach for Mapping Psychiatric Circuits
Objective: To assess the feasibility of using stereo-electroencephalography (SEEG) depth electrodes, implanted for invasive recording of the epileptogenic zone in drug-resistant epilepsy, to identify and validate novel Deep Brain Stimulation (DBS) targets for psychiatric disorders. Methods: SEEG data from 86 patients with drug-resistant epilepsy implanted at the UK National Hospital for Neurology and Neurosurgery were analysed (6,372 electrode contacts). Normative structural and functional connectomes were combined with meta-analytic functional maps to estimate the probability of each contact engaging networks associated with psychiatric symptoms. A linear model, developed using published data from 80 patients with obsessive-compulsive disorder (OCD) treated with DBS, was used to validate the approach. Results: Networks involved in reward processing emerged as the most promising DBS targets, with a predicted required sample size of 7 patients (range 4–33). Bipolar disorder was the next most feasible (22 patients; range 10–44), followed by depression (32; range 16–49) and anxiety (38; range 17–59). For other disorders, estimated sample sizes exceeded 40, indicating limited feasibility for single-centre studies. Conclusions: This study provides preliminary support for using SEEG to map brain circuits underlying psychiatric symptoms. The method leverages routinely implanted electrodes in epilepsy to explore candidate DBS targets, supporting a network-guided strategy for personalised neuromodulation in neuropsychiatry.
- Open Access
- 16 June 2025
- Published by Wiley in Annals of Neurology
- Vol. 98 (3) , 547-560
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study
Objective: Epilepsy surgery needs predictive features that are easily implemented in clinical practice. Previous studies are limited by small sample sizes, lack of external validation, and complex computational approaches. We aimed to identify and validate visually stereo‐electroencephalography (SEEG) features with the highest predictive value for surgical outcome, and assess the reliability of their visual extraction.Methods: We included 177 patients with drug‐resistant epilepsy who underwent SEEG‐guided surgery at 4 epilepsy centers. We assessed the predictive performance of 10 SEEG features from various SEEG periods for surgical outcome, using the area under the receiver operating characteristic curve, and considering resected channels and surgical outcome as the gold standard. Findings were validated externally using balanced accuracy. Six experts, blinded to outcome, evaluated the visual reliability of the optimal feature using interrater reliability, percentage agreement (standard deviation ± SD) and Gwet's kappa (κ ± SD).Results: The derivation cohort comprised 100 consecutive patients, each with at least 1‐year of postoperative follow up (40% temporal lobe epilepsy; 42% Engel Ia). Spatial co‐occurrence of gamma spikes and preictal spikes emerged as the optimal predictive feature of surgical outcome (area under the receiver operating characteristic curve 0.82). Applying the optimized threshold from the derivation cohort, external validation in 2 datasets showed similar performances (balanced accuracy 69.2% and 73.2%). Expert interrater reliability for gamma spikes (percentage agreement, 96% ± 2%; κ, 0.63 ± 0.16) and preictal spikes (percentage agreement, 92% ± 2%; κ, 0.65 ± 0.18) were substantial.Interpretation: Spatial co‐occurrence of gamma spikes and preictal spikes predicts surgical outcome. These visually identifiable features may reduce the burden of SEEG analysis by reducing analysis time, and improve outcome by guiding surgical resection margins. ANN NEUROL 2025;98:547–560
- 16 June 2025
- Published by Wiley in Annals of Neurology
- Vol. 98 (3) , 547-560
Open AccessVisual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study
Objective: Epilepsy surgery needs predictive features that are easily implemented in clinical practice. Previous studies are limited by small sample sizes, lack of external validation, and complex computational approaches. We aimed to identify and validate visually stereo‐electroencephalography (SEEG) features with the highest predictive value for surgical outcome, and assess the reliability of their visual extraction.Methods: We included 177 patients with drug‐resistant epilepsy who underwent SEEG‐guided surgery at 4 epilepsy centers. We assessed the predictive performance of 10 SEEG features from various SEEG periods for surgical outcome, using the area under the receiver operating characteristic curve, and considering resected channels and surgical outcome as the gold standard. Findings were validated externally using balanced accuracy. Six experts, blinded to outcome, evaluated the visual reliability of the optimal feature using interrater reliability, percentage agreement (standard deviation ± SD) and Gwet's kappa (κ ± SD).Results: The derivation cohort comprised 100 consecutive patients, each with at least 1‐year of postoperative follow up (40% temporal lobe epilepsy; 42% Engel Ia). Spatial co‐occurrence of gamma spikes and preictal spikes emerged as the optimal predictive feature of surgical outcome (area under the receiver operating characteristic curve 0.82). Applying the optimized threshold from the derivation cohort, external validation in 2 datasets showed similar performances (balanced accuracy 69.2% and 73.2%). Expert interrater reliability for gamma spikes (percentage agreement, 96% ± 2%; κ, 0.63 ± 0.16) and preictal spikes (percentage agreement, 92% ± 2%; κ, 0.65 ± 0.18) were substantial.Interpretation: Spatial co‐occurrence of gamma spikes and preictal spikes predicts surgical outcome. These visually identifiable features may reduce the burden of SEEG analysis by reducing analysis time, and improve outcome by guiding surgical resection margins. ANN NEUROL 2025;98:547–560
- Open Access
Decoupling simultaneous motor imagination and execution via orthogonal ECoG neural representations
The brain coordinates multiple parallel motor programs, ensuring synergy and preventing interference during movements. Yet, performance often degrades when brain–machine interfaces are used during concurrent tasks or ongoing movements. We suggest that latent neural representations may represent a strategy to solve this issue. In this study, we addressed this question using neural signals from a tetraplegic individual with partial residual motor function, implanted with a wireless epidural electrocorticography (ECoG) device. By adapting dimensionality reduction techniques, we found that motor execution and motor imagery span partially overlapping subspaces in mesoscale neural signals, shaped by specific frequency band contributions. Despite substantial shared variance, we show that identifying orthogonal, condition-specific dimensions enables successful decoding of executed and imagined movements, even when performed simultaneously. These findings show that ECoG signals can expose separable neural subspaces, allowing executed and imagined actions to be harnessed independently and in concert. This opens a promising avenue to develop brain–machine interfaces that can simultaneously control multiple external devices or operate alongside natural movements.
Open AccessDecoupling simultaneous motor imagination and execution via orthogonal ECoG neural representations
The brain coordinates multiple parallel motor programs, ensuring synergy and preventing interference during movements. Yet, performance often degrades when brain–machine interfaces are used during concurrent tasks or ongoing movements. We suggest that latent neural representations may represent a strategy to solve this issue. In this study, we addressed this question using neural signals from a tetraplegic individual with partial residual motor function, implanted with a wireless epidural electrocorticography (ECoG) device. By adapting dimensionality reduction techniques, we found that motor execution and motor imagery span partially overlapping subspaces in mesoscale neural signals, shaped by specific frequency band contributions. Despite substantial shared variance, we show that identifying orthogonal, condition-specific dimensions enables successful decoding of executed and imagined movements, even when performed simultaneously. These findings show that ECoG signals can expose separable neural subspaces, allowing executed and imagined actions to be harnessed independently and in concert. This opens a promising avenue to develop brain–machine interfaces that can simultaneously control multiple external devices or operate alongside natural movements.
- Open Access
- 6 April 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (9) , 4274-4285
Deconstructing a common pathway concept for Deep Brain Stimulation in the case of Obsessive-Compulsive Disorder
Deep Brain Stimulation (DBS) is a therapeutic option for treatment resistant (TR) obsessive-compulsive disorder (OCD). The OCD network comprises different sub-networks with homeostatic functions, altered under disease and modifiable with DBS. Connectomic analyses of DBS data sets have defined fiber selections explaining anti-OCD efficacy. This is a retrospective stimulation and outcome derived anatomical overlay analysis of 26 TR-OCD patients who received DBS at two academic centers. Grenoble, 14 anteromedial subthalamic nucleus (amSTN); Freiburg, 12 superolateral medial forebrain bundle (slMFB). Yale-Brown Obsessive Compulsive Scale improvement at 24 months served as outcome parameter. Structural proximity and outcomes were correlated using individual volumes of activated tissue for STN, slMFB, ORT (average OCD response tract) and further structures based on atlases or established connectomes. Connectomes (slMFB, ORT) were inspected for structural congruences. Normative connectomic data served to investigate cortical fiber penetration for the two target regions. Cortical sub-network conjugations were evaluated as peak levels. Our analyses revealed that ORT represents a fiber selection from the slMFB. DBS of amSTN and slMFB each address distinctive sub-networks while deep amSTN DBS can also address slMFB. Sub-network conjugations project amongst other regions onto the dorsomedial prefrontal cortex (dmPFC). The average ORT fiber selection is an integral part of the generic slMFB. Anti-OCD effects of amSTN DBS are not entirely explained by ORT overlay. The slMFB is dispersed and encompasses all OCD sub-networks and might qualify as a common DBS target when stimulated close to the ventral tegmental area. The dmPFC emerges as an interesting conjugation/hub between OCD sub-networks.
- 6 April 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (9) , 4274-4285
Open AccessDeconstructing a common pathway concept for Deep Brain Stimulation in the case of Obsessive-Compulsive Disorder
Deep Brain Stimulation (DBS) is a therapeutic option for treatment resistant (TR) obsessive-compulsive disorder (OCD). The OCD network comprises different sub-networks with homeostatic functions, altered under disease and modifiable with DBS. Connectomic analyses of DBS data sets have defined fiber selections explaining anti-OCD efficacy. This is a retrospective stimulation and outcome derived anatomical overlay analysis of 26 TR-OCD patients who received DBS at two academic centers. Grenoble, 14 anteromedial subthalamic nucleus (amSTN); Freiburg, 12 superolateral medial forebrain bundle (slMFB). Yale-Brown Obsessive Compulsive Scale improvement at 24 months served as outcome parameter. Structural proximity and outcomes were correlated using individual volumes of activated tissue for STN, slMFB, ORT (average OCD response tract) and further structures based on atlases or established connectomes. Connectomes (slMFB, ORT) were inspected for structural congruences. Normative connectomic data served to investigate cortical fiber penetration for the two target regions. Cortical sub-network conjugations were evaluated as peak levels. Our analyses revealed that ORT represents a fiber selection from the slMFB. DBS of amSTN and slMFB each address distinctive sub-networks while deep amSTN DBS can also address slMFB. Sub-network conjugations project amongst other regions onto the dorsomedial prefrontal cortex (dmPFC). The average ORT fiber selection is an integral part of the generic slMFB. Anti-OCD effects of amSTN DBS are not entirely explained by ORT overlay. The slMFB is dispersed and encompasses all OCD sub-networks and might qualify as a common DBS target when stimulated close to the ventral tegmental area. The dmPFC emerges as an interesting conjugation/hub between OCD sub-networks.